Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis
Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …
vaccination was implemented. We did a systematic review and meta-analysis of the …
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Background Human papillomavirus (HPV) vaccination programmes were first implemented
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …
in several countries worldwide in 2007. We did a systematic review and meta-analysis to …
[HTML][HTML] Sexually transmitted infections treatment guidelines, 2021
KA Workowski - MMWR. Recommendations and Reports, 2021 - cdc.gov
These guidelines for the treatment of persons who have or are at risk for sexually transmitted
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …
infections (STIs) were updated by CDC after consultation with professionals knowledgeable …
Significant reduction in the incidence of genital warts in young men 5 years into the danish human papillomavirus vaccination program for girls and women
S Bollerup, B Baldur-Felskov, M Blomberg… - Sexually transmitted …, 2016 - journals.lww.com
Background Denmark introduced the quadrivalent human papillomavirus vaccine into the
vaccination program for 12-to 15-year-old girls in 2008 to 2009. In 2012, the program was …
vaccination program for 12-to 15-year-old girls in 2008 to 2009. In 2012, the program was …
[HTML][HTML] Cervical cancer screening in women vaccinated against human papillomavirus infection: Recommendations from a consensus conference
In Italy, the cohorts of women who were offered Human papillomavirus (HPV) vaccination in
2007/08 will reach the age (25 years) for cervical cancer (CC) screening from 2017. The …
2007/08 will reach the age (25 years) for cervical cancer (CC) screening from 2017. The …
Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions
C Dehlendorff, P Sparén, B Baldur-Felskov… - Vaccine, 2018 - Elsevier
Background Based on immunogenicity studies, a 2 dose HPV vaccination-schedule was
recently recommended for girls younger than 15 years. We aimed to investigate the …
recently recommended for girls younger than 15 years. We aimed to investigate the …
Dissecting the indirect effects caused by vaccines into the basic elements
CD Scarbrough Lefebvre, A Terlinden… - Human vaccines & …, 2015 - Taylor & Francis
Vaccination directly protects vaccinated individuals, but it also has the potential for indirectly
protecting the unvaccinated in a population (herd protection). Unintended negative …
protecting the unvaccinated in a population (herd protection). Unintended negative …
Impact of HPV vaccination on anogenital warts and respiratory papillomatosis
Z Wangu, KK Hsu - Human vaccines & immunotherapeutics, 2016 - Taylor & Francis
Human papillomavirus (HPV), the most common sexually transmitted infection in the US and
worldwide, can cause cancers, anogenital warts (AGW), and recurrent respiratory …
worldwide, can cause cancers, anogenital warts (AGW), and recurrent respiratory …
Recent progress in vaccination against human papillomavirus‐mediated cervical cancer
SJ McKee, AS Bergot… - Reviews in medical …, 2015 - Wiley Online Library
It has been more than 7 years since the commercial introduction of highly successful
vaccines protecting against high‐risk human papillomavirus (HPV) subtypes and the …
vaccines protecting against high‐risk human papillomavirus (HPV) subtypes and the …
Real-world impact and effectiveness assessment of the quadrivalent HPV vaccine: a systematic review of study designs and data sources
Introduction Vaccine effectiveness and impact studies are typically observational, generating
evidence after vaccine launch in a real-world setting. For human papillomavirus (HPV) …
evidence after vaccine launch in a real-world setting. For human papillomavirus (HPV) …